January 2020 - Page 2 of 4 - EAS Consulting Group

Developing a Mobile Medical Device? FDA Is Watching

Jan 6, 2020 | EAS in the News Medical Device, Medical Devices

MedTech Intelligence January 6, 2020 Developing a Mobile Medical Device? FDA Is Watching Amy...

David Cockram, Ph.D.

Jan 1, 2020 | Who’s Who at EAS

David Cockram assists EAS clients in the areas of GRAS, Infant Formula and NDI study design, execution and monitoring in support of safety submissions for novel food and dietary ingredients and nutritional products. He recently retired as Senior Director of Global...

Discussion of Big Data and Real-World Evidence in ISPE iSpeak

Jan 1, 2020 | EAS in Action, EASeNews

Are you considering strategic regulatory pathways for a development of New Chemical Entity and biologics?

Radhika Rajagopalan

Jan 1, 2020 | Who’s Who at EAS

Radhika Rajagopalan, Ph.D. is a former Quality Assessment Lead, Expert Reviewer in ANDA Stability Testing at FDA. She has decades of experience with CMC packages including ANDAs, DMFs (Type 2 and 4), INDs, Bio-INDs, OTCs, supplemental new drug applications, novel...

Jon Anderson

Jan 1, 2020 | Who’s Who at EAS

Jon Anderson assists EAS clients with occupational safety standards and compliance, conducting audits and customized trainings for manufacturing plants, distribution centers and warehouses to ensure a culture of safety specific to each work environment. He provides...